Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
Authors:
- Margaret C. LannonMLMargaret C. Lannon
- 1 May 2000
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 15 (3) , 579-581
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Worsening of motor features of Parkinsonism with olanzapineMovement Disorders, 1999
- Quetiapine for the treatment of drug-induced psychosis in Parkinson's diseaseMovement Disorders, 1999
- Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidoneNeurology, 1999
- The Role of Atypical Antipsychotics in the Treatment of Movement DisordersCNS Drugs, 1999
- Olanzapine can worsen parkinsonismNeurology, 1998
- Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's diseaseNeurology, 1998
- The Clinician-Scientist in NeuropsychiatryThe Journal of Neuropsychiatry and Clinical Neurosciences, 1998
- Risk factors for nursing home placement in advanced Parkinson's diseaseNeurology, 1993
- Seroquel: biochemical profile of a potential atypical antipsychoticPsychopharmacology, 1993
- The Management of the Levodopa PsychosesClinical Neuropharmacology, 1991